Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-989-9 | CAS number: 112-60-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Developmental toxicity studies conduced in rodents with lower category members, diethylene glycol and triethylene glycol, did not result in reproductive toxicity.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 6 780 mg/kg bw/day
- Study duration:
- chronic
- Species:
- mouse
- Quality of whole database:
- Acceptable
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- Acceptable
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
In the 2-generation key study, a Fertility Assessment by Continuous Breeding study (National Toxicology Program, 1984), diethylene glycol (DEG) was administered via the drinking water to 40 male and 40 female mice at concentrations of 0, 0.35, 1.75, and 3.5% (equivalent to approximately 0, 612, 3063, and 6125 mg/kg/day) for 7 days premating, a 98 day cohabitation period, and 21 days after cohabitation (study Task 2). Task 3 was performed by cross-mating the control and high dose Task 2 parental animals. In Task 4, the control and mid-dose offspring from the final Task 2 litters were mated. Exposure to DEG at levels up to 3.5% produced no significant adverse effects on fertility in Tasks 2, 3, or 4. Results from the Task 2 litter analyses show the high dose group to have a significantly decreased number of litters, with decreased litter size and adjusted pup weight. No significant differences were observed in the low or mid-dose groups. In Task 3, the only significant result observed in the litter analysis was a decrease in mean pup weight in the control male-high dose female breeding group. At necropsy, body weight in high dose females was decreased by 7% (p<0.01). No significant differences in adjusted organ weights were found for either sex. In Task 4, no significant effects were observed in fertility or litter analysis. Body weight at necropsy was significantly decreased in the mid-dose group of both sexes. Relative to controls, mid-dose males weighed 11% less and mid-dose females weighed 7% less. Mid-dose males were found to have significantly increased (by 11%) liver weights. There were no significant changes in female organ weights. No effect on any of the sperm parameters was observed in Task 3 or 4.The NOAEL for fertility and reproductive toxicity was 3063 mg/kg/day.
In a Reproductive Assessment by Continuous Breeding study with TEG (Bossert et al., 1992), groups of Swiss CD-1 mice were exposed to 0, 0.3, 1.5, and 3% (equivalent to 0, 590, 3300, and 6780 mg/kg bw/day) TEG in the drinking water during a 98-day cohabitation period. No reproductive toxicity in either generation was observed at concentrations up to 3%. Reduced pup body weight was observed at the mid and high dose levels in F1 offspring only. No effect on pup body weight was seen in F2 offspring. No effect of treatment on the proportion of pairs with a litter, the number of litters per pair, the number of live pups per litter or the proportion of live born pups in the study. Therefore, the NOAEL for parental toxicity and for fertility was 6780 mg/kg bw/day.
Justification for selection of reproductive toxicity – oral route
The NOAEL for reproductive toxicity is based on the murine
continuous breeding study for TEG, the closest ethylene glycol component
in this category. Although direct reproductive toxicity data are not
available for TTEG, the lack of findings with the lower ethylene glycols
supports conclusion of low potential of reproductive toxicity and effect
on fertility across this class of compounds.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 5 630 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Very good.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
In the key developmental toxicity study by Bushy Run Research Center (1991; Ballantyne and Snellings 2005b), Sprague-Dawley rats received doses of 1, 5, and 10 ml/kg TEG by oral gavage (equivalent to 1126, 5630, and 11260 mg/kg bw/day) on gestation days 6 through 15. Maternal toxicity was characterized by body weight reductions at 5 and 10 ml/kg/day, decreased body weight gain at 10 ml/kg/day, treatment associated clinical signs at 10 ml/kg/day, reduced food consumption at 5 and 10 ml/kg/day, increased water consumption at 5 and 10 ml/kg/day, and increased relative kidney weight with no correlated histopathologic changes at 10 ml/kg/day. Fetal body weights were reduced at 10 ml/kg/day and treatment-related reduced ossification of the thoracic region was observed at this dose level. The NOEL for maternal toxicity was 1 ml/kg/day (1100 mg/kg/day) and the NOEL for developmental toxicity was 5 ml/kg/day (5630 mg/kg/day).
Developmental toxicity of TEG has also been assessed in mice. In a supporting study, CD-1 mice received doses of 0.5, 5, and 10 ml/kg/day by oral gavage (equivalent to 563, 5630, and 11260 mg/kg bw/day) on days 6 through 15 of gestation (Bushy Run Research Center, 1990; Ballantyne and Snellings 2005b; Dow 2015). Clinical signs observed at 10 ml/kg/day included hypoactivity and audible and rapid respiration. A treatment related decrease in body weight gain was observed at the 10 ml/kg/day dose level and a treatment related decrease in body weight gain corrected for gravid uterine weight was observed at 5 and 10 ml/kg/day dose levels (Dow, 2015). Water consumption was increased at the mid and high dose (Dow, 2015). Relative kidney weight was significantly increased at 10.0 ml/kg/day, but no histopathologic changes were observed (BRRC, 1990). Decreased fetal weight and delayed bone ossification observed at 5 and 10 ml/kg/day represent a fetal developmental delay secondary to maternal toxicity (BRRC, 1990). The NOEL for both maternal toxicity and developmental toxicity was 0.5 ml/kg/day (563 mg/kg/day) (Dow, 2015).
In a supporting developmental toxicity study by Hellwig et al. (1995), Himalayan rabbits were exposed to nominal concentrations of 100, 400, and 1000 mg/kg bw/day diethylene glycol (DEG) by oral gavage on gestation days 7 through 19. No adverse effects attributed to DEG exposure were observed in does or fetuses. Any observed differences between dose groups were without a clear dose response relationship or were within historical control values and, therefore, determined not biologically relevant. The NOAEL for maternal toxicity, embryotoxicity and fetotoxicity were the high dose of 1000 mg/kg bw/day. This is the key study because rabbits are considered the most relevant species for hazard assessment of this chemistry.
Adverse developmental effects related to gestational exposure to DEG and TEG predominantly consisted of decreased fetal weight and related delays in skeletal ossification in rodents. These effects were found secondary to maternal toxicity and in all cases were observed at doses exceeding the current guideline limit dose for developmental toxicity studies. Delayed ossification is not considered adverse as these variations would be fully expected to ossify postnatally and would have no impact on the viability or function of the offspring (Carney and Kimmel, 2007; Marr et al., 1992). Pup weights would also be expected to reach the control levels postnatally (Marr et al., 1992). Because adverse reproductive effects are expected to decrease with increasing number of oxyethylene repeat units, similarly low potential for developmental toxicity is expected for tetraethylene glycol (TTEG). No effects on the development were seen in rabbit with DEG, the most relevant species for human hazard assessment for this chemistry. Therefore, based on the category members, TTEG is not expected to produce adverse effects on development.
Justification for selection of developmental toxicity – oral route
Adverse reproductive effects are expected to decrease with
increasing number of oxyethylene repeat units per molecule in rodents
only. These effects seen in the lower ethylene glycols (DEG, TEG) were
seen secondary to maternal toxicity and at doses exceeding current limit
dose for guideline developmental toxicity studies. The dose descriptor
for TTEG is based on data from the closest ethylene glycol category
member.
Toxicity to reproduction: other studies
Additional information
Developmental toxicity studies of category members, diethylene glycol and triethylene glycol, in rodents have also been conducted. High doses that resulted in maternal toxicity did not produce developmental toxicity to fetuses.
Justification for classification or non-classification
Classification according to GHS and the Directive 67/548/EEC (DSD) regarding reproductive toxicity and developmental toxicity/teratogenicity is not warranted.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.